Approval · Notice of Compliance 20994 · 2018
PROGRAM 40: Notice of Compliance 20994
Issued June 18, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20994
- Date
- June 18, 2018
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROGRAM 40 | 02237517 | Cancelled Post Market |
| PROGRAM 80 | 02237516 | Cancelled Post Market |